Visual Sensitivity Loss in Geographic Atrophy: Structure-Function Evaluation Using Defect-Mapping Microperimetry.

"Disclosure: Z. Wu, None; X. Hadoux, None; M. Jannaud, None; E.K. Glover, None; E.E. Gee, None; L.A.B. Hodgson, None; P. van Wijngaarden, reports personal fees from Roche/Genentech, Bayer, Novartis, and Mylan outside the submitted work; R. H. Guymer, reports personal fees from Roche/Genentech, Bayer, Novartis and Apellis outside the submitted work"

"Supported by the National Health & Medical Research Council of Australia (#2008382 [Z.W.] and #1194667 [R.H.G.]), the BrightFocus Foundation (#M2019073 [ZW and RHG]) and Apellis Pharmaceuticals (investigator-initiated trial grant [ZW and RHG]). CERA receives operational infrastructure support from the Victorian Government. The funders had no role in the manuscript writing and the decision to submit the manuscript for publication."